Eurofins Cosmetics & Personal Care partners with PEPPER Platform to Pre-validate Characterisation Methods for Endocrine Disruptors
13 July 2021
Eurofins Cosmetics & Personal Care partners with PEPPER Platform to pre-validate characterisation methods for endocrine disruptors
Eurofins is expanding its global innovation capabilities through new partnerships to drive innovative characterisation methods for endocrine disruptors. Eurofins is partnering with the PEPPER Platform regarding pre-validation of endocrine disruptor characterisation methods. PEPPER is a large international project involving key stakeholders of the endocrine disruptors space: health, environmental authorities and companies
Interest in endocrine disruptors has grown, driven by concern for consumer safety and the constant and challenging requirement to provide safe cosmetic products. The scientific challenge of assessing the impact of cosmetic products on human health and safety and ensuring adequate validation methods are used is an important public health matter.
Eurofins is one of the major players in this type of cosmetic product testing, having developed a combined in vitro method to screen potential endocrine disruptors, based on existing test methods and approaches. As a member of many international committees, and with a team of dedicated experts, Eurofins carries out important assessment work on the Placentox method. PEPPER Platform’s strategy of performing method and assay pre-validation within (eco)toxicology is aligned with the Eurofins Group’s mission to contribute to a safer and healthier world. Together, PEPPER and Eurofins will work on specific projects; in particular, organising testing of the Placentox method, with the aim of submitting this method and required scientific reports to international validation bodies.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
About Eurofins Cosmetics & Personal Care
Eurofins Cosmetics & Personal Care is a leading provider in cosmetics and personal care testing worldwide, offering the most comprehensive service portfolio from its state-of-the-art cosmetics testing laboratories across the globe. With a network of over 26 high-level laboratories active in the field across Europe, North America, Asia, Australia and Africa, Eurofins Cosmetics & Personal Care offers an unmatched range of services to both top-tier international and local clients, including: regulatory and toxicological services, physico-chemical analyses, microbiology, ecotoxicity and biodegradability, in vitro testing, clinical studies, consumer tests and sensory evaluation, and audit and consulting services.
About PEPPER Platform
PEPPER is the first public private Platform dedicated to the pre-validation of endocrine disruptors characterization methods. The project has been piloted by stakeholders from both industrial sectors and ministerial divisions. It is part of the National Strategy on Endocrine Disruptors (SNPE), designed by the ministries in charge of Health and in charge on the Environment.
The platform aims to perform the prevalidation of methods and assays in toxicology and ecotoxicology, that have been identified as relevant for the characterization of endocrine disruption properties. The platform will ensure that candidate methods are of sufficient quality, and will build up the proofs that are required by the international bodies in charge of validation (OECD, ECVAM, ISO, CEN ..). Once validated by the bodies in charge of mutual acceptance, such methods can be used in dossiers related to regulations on substances (REACh, Biocides, Phytopharmaceuticals…), products (e.g. medical devices), or environments (e.g. Water Framework Directive).
You must be logged in to post a comment.